How will the new guideline for managing otitis media work in your practice?

The first round of recommendations from two expert groups illuminates several areas: diagnostic criteria, pain management, observational management, and the use-or withholding-of initial antibiotics. Here is a sweeping review of what the guideline might mean for the kind of care you give.

Related Videos
FDA approves B-VEC to treat dystrophic epidermolysis bullosa patients 6 months and older | Image Credit: bankrx - Image Credit: bankrx -
Pfizer's infant RSV vaccine receives FDA Advisory Committee's support | Image Credit: Dr_Microbe - Image Credit: Dr_Microbe
Thomas R. Young, MD | Image Credit: Author provided
J. Thomas Megerian, MD, PhD, FAAP | Author provided
Jonathan Miller, MD
Steven Selbst, MD
© 2023 MJH Life Sciences

All rights reserved.